This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier Announces The Launch Of Open Access Journal

AMSTERDAM, December 23, 2013 /PRNewswire/ --

Interdisciplinary Neurosurgery: Advanced Techniques and Case Management

Elsevier, a world-leading provider of scientific, technical and medical information, products and solutions announces the launch of open access journal, Interdisciplinary Neurosurgery: Advanced Techniques and Case Management .

Neurosurgery has recently seen a range of advances in imaging techniques and experimental research in the field of neurorestoration and neuroregeneration, offering new treatment options for neurosurgeons, such as stem cell treatment and implanting of biotechnical devices.

Interdisciplinary Neurosurgery will provide a new home for high quality manuscripts, of interest to clinical researchers in the field of neurosurgery and neurology, and clinicians of related disciplines who are involved in the treatment of central and peripheral nervous system diseases and the spine.

Editor-in-Chief of the journal, Petra Klinge, Associate Professor of Neurosurgery, The Warren Alpert Medical School of Brown University, said of the launch, "Neurosurgery is often tasked to manage the more difficult and rare cases. Interdisciplinary Neurosurgery is dedicated to publishing those complex neurosurgical cases, particularly when other specialties are involved in the diagnosis and management. Neuroimaging, robotics, biotechnics and basic neurosciences are offering new opportunities for the management of neurological diseases at an ever increasing speed. Not only does this broaden the spectrum of neurosurgical indications (e.g. in the field of neurorestoration) but also welcomes an increasingly innovative approach to inter- and transdisciplinary collaboration."

"We're delighted to announce the launch of this new journal. We look forward to offering surgeons, researchers and clinicians a platform on which they can publish cases that propose new and unconventional ideas, and introduce new diagnostic tools while promoting cutting-edge neurosurgery," said Peter Bakker, Publisher Neurology at Elsevier. "Authors and readers alike will benefit from the various features that Interdisciplinary Neurosurgery has to offer. As an open access, online only, article based publishing journal, research will be available to all researchers anytime and from any location on ScienceDirect"

The article based publishing model allows for immediate publication of the final version of a paper without waiting for other articles to be compiled into a full issue. This, amongst other Elsevier content innovation initiatives, will ensure that Interdisciplinary Neurosurgery delivers accessible and current content with reduced publication delays.

The first published articles will become available for access online on ScienceDirect in the first quarter of 2014.  

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs